Sign Up Today and Learn More About CellMax Life Stock
Invest in or calculate the value of your shares in CellMax Life or other pre-IPO companies through EquityZen's platform.
CellMax Life Stock (CELI)
CellMax Life is a biotechnology company that is focused on developments in early cancer detection and prevention.
About CellMax Life Stock
Founded
2013
Headquarters
Mountain View, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
CellMax Life is a biotechnology company that is revolutionizing early cancer detection and prevention. The company’s product portfolio includes a blood test that can detect cancer before it is too late. CellMax Life was founded in 2013 and is based in California, United States. The company has offices in Silicon Valley (U.S.) and Taiwan, and is funded by a venture capital firm in the U.S. and technology industrialists in Taiwan.
CellMax Life Press Mentions
Stay in the know about the latest news on CellMax Life
CellMax Life Appoints Dr. Ross D. “Rusty” Segan to Advisory Board
prweb • Aug 04, 2023
People in the News at CellMax Life, Jackson Lab, BC Platforms, GeneDx
genomeweb • Apr 08, 2023
Opinion
news-medical • Jul 28, 2018
CellMax Life’s Early Cancer Detection Platform Wins 2018 MedTech Breakthrough Award
prweb • Jun 06, 2018
CellMax Life Launches Zenith, a U.S. Clinical Study for the Advancement of Blood Tests for Early Cancer Detection, With the Goal of Seeking FDA Approval
prnewswire • May 30, 2018
CellMax Life Management
Leadership team at CellMax Life
Board Member
Amit Shah
Co-Founder
Ying-Chih Chang
Join now and verify your accreditation status to gain access to:
- CellMax Life Current Valuation
- CellMax Life Stock Price
- CellMax Life Management
- Available deals in CellMax Life and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- CellMax Life Cap Table and Funding History by Share Class and Liquidity Preferences
- CellMax Life Revenue and Financials
- CellMax Life Highlights
- CellMax Life Business Model
- CellMax Life Risk Factors
- CellMax Life Research Report from SACRA Research
Trading CellMax Life Stock
How to invest in CellMax Life stock?
Accredited investors can buy pre-IPO stock in companies like CellMax Life through EquityZen funds. These investments are made available by existing CellMax Life shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell CellMax Life stock?
Shareholders can sell their CellMax Life stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
